The National Cancer Institute (NCI) has designated Yale Cancer Center as one of only 49 Comprehensive Cancer Centers
in the country via a rigorous P30 grant application and review process. Through 43 years of continuous funding, YCC has demonstrated that it provides (as written here
- Cancer research that spans laboratory science, clinical research, and population-based research.
- Clinical programs that offer patients the latest forms of treatment for a wide range of cancers, as well as access to clinical trials of experimental treatments.
- Training for scientists, physicians, surgeons, and other professionals seeking specialized training or board certification in cancer-related disciplines
- Public education and outreach about cancer prevention and screening, with special attention to the needs of underserved populations.
In addition to the above requirements that all NCI-designated Cancer Centers must meet, YCC has met the following additional requirements to be a Comprehensive Cancer Center:
- Substantial transdisciplinary research that bridges these scientific areas.
- Demonstrated professional and public education and outreach capabilities, including dissemination of clinical and public health advances in the communities it serves.
Members may contribute to any of the four missions of the Cancer Center: research, education, clinical investigations, and dissemination and administration.